✦ LIBER ✦

Galangin increases the cytotoxic activity of imatinib mesylate in imatinib-sensitive and imatinib-resistant Bcr-Abl expressing leukemia cells

✍ Scribed by Manlio Tolomeo; Stefania Grimaudo; Antonietta Di Cristina; Rosaria M. Pipitone; Luisa Dusonchet; Maria Meli; Lucia Crosta; Nicola Gebbia; Francesco Paolo Invidiata; Lucina Titone; Daniele Simoni

Book ID: 116334699
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 421 KB
Volume: 265
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2008.02.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NF-κB inhibition triggers death of imati

NF-κB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants

✍ Nadia Lounnas; Catherine Frelin; Nadège Gonthier; Pascal Colosetti; Anne Sirvent 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 521 KB

## Abstract The Bcr‐Abl inhibitor imatinib is the current first‐line therapy for all newly diagnosed chronic myeloid leukemia (CML). Nevertheless, resistance to imatinib emerges as CML progresses to an acute deadly phase implying that physiopathologically relevant cellular targets should be validat

Effect of imatinib on the signal transdu

Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL–positive) cells sensitive and resistant to imatinib

✍ Rahav Mor-Tzuntz; Orit Uziel; Ofer Shpilberg; Judith Lahav; Pia Raanani; Mary Ba 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 698 KB

Efficacy of dual-specific Bcr-Abl and Sr

Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate

✍ Tipping, A J; Baluch, S; Barnes, D J; Veach, D R; Clarkson, B M; Bornmann, W G; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 132 KB

Increasing the BCR-ABL expression levels

Increasing the BCR-ABL expression levels and/or the occurrence of ABL point mutations does not always predict resistance to Imatinib Mesylate in BCR-ABL positive acute lymphoblastic leukemia

✍ S. Grammatico; L. Elia; A.L. Peluso; L. Pedace; M. Matarazzo; A. Vitale; A. Rago 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Bortezomib decreases Rb phosphorylation

Bortezomib decreases Rb phosphorylation and induces caspase-dependent apoptosis in Imatinib-sensitive and -resistant Bcr-Abl1-expressing cells

✍ Albero, M P; Vaquer, J M; Andreu, E J; Villanueva, J J; Franch, L; Ivorra, C; Po 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 820 KB

The Proteolytic Activity of Separase in

The Proteolytic Activity of Separase in BCR-ABL-Positive Cells Is Increased by Imatinib

✍ Haaß, Wiltrud; Stehle, Michael; Nittka, Stefanie; Giehl, Michelle; Schrotz-King, 📂 Article 📅 2012 🏛 Public Library of Science 🌐 English ⚖ 816 KB